MYD88 and liver cancer: TLR4 signaling reduces HBV replication via MAPK and PI-3 K/Akt. TLR signaling plays an important role in hepatocarcinogenesis as demonstrated by a decrease in liver cancer occurrence, size, and quantity in TLR4 and MyD88 deficient mice.